QHSLab (STU:E1Z) Cyclically Adjusted PB Ratio: (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:E1Z QHSLab Inc STU:E1Z
50 GF Score
Price €0.22
GF Value €0.13
! 3 Warning Signs
View Full Analysis

What is QHSLab Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


QHSLab  (STU:E1Z) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


QHSLab Cyclically Adjusted PB Ratio Related Terms


QHSLab Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for QHSLab's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QHSLab Cyclically Adjusted PB Ratio Chart

QHSLab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

QHSLab Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:E1Z vs VVOS, STME, AMIX: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, QHSLab's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where QHSLab's Cyclically Adjusted PB Ratio falls into.


STU:E1Z
50GF Score
QHSLab Inc STU:E1Z
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QHSLab Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

QHSLab's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, QHSLab's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.09/333.9520*333.9520
=0.090

Current CPI (Jun. 2026) = 333.9520.

QHSLab Quarterly Data

Book Value per Share CPI Adj_Book
201609 -0.119 241.428 -0.165
201612 -0.128 241.432 -0.177
201703 -0.126 243.801 -0.173
201706 -0.121 244.955 -0.165
201709 -0.115 246.819 -0.156
201712 -0.116 246.524 -0.157
201803 -0.113 249.554 -0.151
201806 -0.124 251.989 -0.164
201809 -0.126 252.439 -0.167
201812 -0.131 251.233 -0.174
201903 -0.135 254.202 -0.177
201906 -0.136 256.143 -0.177
201909 -0.074 256.759 -0.096
201912 -0.067 256.974 -0.087
202003 -0.080 258.115 -0.104
202006 -0.076 257.797 -0.098
202009 -0.077 260.280 -0.099
202012 -0.076 260.474 -0.097
202103 -0.050 264.877 -0.063
202106 0.054 271.696 0.066
202109 0.057 274.310 0.069
202112 0.083 278.802 0.099
202203 0.070 287.504 0.081
202206 0.044 296.311 0.050
202209 0.031 296.808 0.035
202212 0.008 296.797 0.009
202303 -0.011 301.836 -0.012
202306 -0.021 305.109 -0.023
202309 -0.030 307.789 -0.033
202312 -0.035 306.746 -0.038
202403 -0.034 312.332 -0.036
202406 -0.034 314.175 -0.036
202409 -0.029 315.301 -0.031
202412 -0.054 315.605 -0.057
202503 -0.048 319.799 -0.050
202506 -0.049 322.561 -0.051
202509 -0.046 324.800 -0.047
202512 0.092 324.054 0.095
202603 0.088 330.213 0.089
202606 0.090 333.952 0.090

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is QHSLab (STU:E1Z) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of €0.22 is trading 72.3% above its estimated GF Value™ of €0.13.

Key valuation signals for STU:E1Z:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.13 vs. price of €0.22 (72.3% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the STU:E1Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QHSLab Business Description

Other Exchanges USAQ:USA
Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
50GF Score

Get the complete analysis for STU:E1Z

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price
€0.13
GF Value